HCP Live
Nuerology Live
Contagion Live
OncLive
Neurology Live
Neurology Live
Spotlight
Clinical Focus
Video Series
Media
Conferences
Partners
Resources
Subscribe
  • Advertise
  • Contact Us
  • Editorial
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy
  • Advisory Board

© 2021 MJH Life Sciences and Neurology Live. All rights reserved.

Spotlight
  • AES 2020
Clinical FocusSee All >
  • Dementia/Alzheimer
  • Epilepsy
  • Headache/Migraine
  • Movement Disorders
  • Multiple Sclerosis
  • Neuromuscular
  • Sleep Medicine
  • Stroke
Video Series
  • Cure Connections
  • Insights
  • News Network
  • Peer Exchange
  • Advertise
  • Contact Us
  • Editorial
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy
  • Advisory Board
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.

Advances in Early Treatment Approaches in Multiple Sclerosis

Updated McDonald Criteria for Diagnosing MS

Diagnostic Work-Up for MS

MRI in the Diagnosis of MS

Clinical Courses in MS

Modern Conversion Rate to Secondary MS

Importance of Early Treatment of MS

Choosing Initial Therapy for Treatment of MS

Factors to Consider for First-Line Therapy for MS

Recent Treatment Strategies Explored for Relapsing MS

ASSESS Clinical Trial of Fingolimod for Treatment of MS

Rebound Management Strategies for MS Therapies

EXPAND Clinical Trial of Siponimod for Treatment of MS

Patient Selection for Alemtuzumab for Treatment of MS

Recent Approvals for MS: Cladribine and Diroximel Fumarate

Review of Natalizumab for MS

Original Drugs to Treat MS

Drugs in Development for MS, Including Ofatumumab

Unmet Needs and Final Thoughts on Treating MS